🇺🇸 Poliomyelitis Vaccine inactivated in United States
13 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 13
Most-reported reactions
- Fatigue — 2 reports (15.38%)
- Immunodeficiency — 2 reports (15.38%)
- Rhabdomyolysis — 2 reports (15.38%)
- Adenoidal Hypertrophy — 1 report (7.69%)
- Alopecia — 1 report (7.69%)
- Angioedema — 1 report (7.69%)
- Anxiety — 1 report (7.69%)
- Aortic Arteriosclerosis — 1 report (7.69%)
- Atelectasis — 1 report (7.69%)
- Attention Deficit/Hyperactivity Disorder — 1 report (7.69%)
Other Infectious Disease approved in United States
Frequently asked questions
Is Poliomyelitis Vaccine inactivated approved in United States?
Poliomyelitis Vaccine inactivated does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Poliomyelitis Vaccine inactivated in United States?
Sanofi Pasteur, a Sanofi Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.